Management of the oldest old with osteoporosis

European Geriatric Medicine

Volumn 1, Issue 1, 2010, Pages 15-21

  Rizzoli, R ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Bisphosphonate; Falls; Frailty; Hip fracture; Nutrition; Osteoporosis; Strontium ranelate; Teriparatide; Vitamin D supplementation

Indexed keywords

ALENDRONIC ACID; CALCIUM; CLODRONIC ACID; DENOSUMAB; IBANDRONIC ACID; PARATHYROID HORMONE[1-34]; PLACEBO; RISEDRONIC ACID; STRONTIUM RANELATE; VITAMIN D; ZOLEDRONIC ACID;

AGING; ARTHRITIS; ARTICLE; BONE STRENGTH; CLINICAL DECISION MAKING; CLINICAL TRIAL; COGNITIVE DEFECT; DEATH; DEPRESSION; DISABILITY; DRUG EFFICACY; DRUG MEGADOSE; ENDURANCE; EXERCISE; EXHAUSTION; FALL RISK; FALLING; FRAGILITY FRACTURE; FRAIL ELDERLY; GAIT; GAIT DISORDER; GERIATRIC CARE; HIP FRACTURE; HOSPITALIZATION; HUMAN; LOW DRUG DOSE; META ANALYSIS; MUSCLE DISEASE; MUSCLE WEAKNESS; NUTRITION; OSTEOPOROSIS; PARENTERAL NUTRITION; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; POSTMENOPAUSE; PROTEIN INTAKE; RESISTANCE TRAINING; RISK FACTOR; SUN EXPOSURE; SYSTEMATIC REVIEW; VERTEBRA FRACTURE; VITAMIN SUPPLEMENTATION; WEIGHT REDUCTION;

EID: 77953567259     PISSN: 18787649     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurger.2009.12.003     Document Type: Article

References (89)

1. Lippuner K., Johansson H., Kanis J.A., and Rizzoli R. Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women. Osteoporos Int 20 7 (2009) 1131-1140
2. Burge R., Dawson-Hughes B., Solomon D.H., Wong J.B., King A., and Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 22 3 (2007) 465-475
3. Abrahamsen B., van Staa T., Ariely R., Olson M., and Cooper C. Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int 20 10 (2009) 1633-1650
4. Schurch M.A., Rizzoli R., Mermillod B., Vasey H., Michel J.P., and Bonjour J.P. A prospective study on socioeconomic aspects of fracture of the proximal femur. J Bone Miner Res 11 12 (1996) 1935-1942
5. Trombetti A., Herrmann F., Hoffmeyer P., Schurch M.A., Bonjour J.P., and Rizzoli R. Survival and potential years of life lost after hip fracture in men and age-matched women. Osteoporos Int 13 9 (2002) 731-737
6. Holroyd C., Cooper C., and Dennison E. Epidemiology of osteoporosis. Best Pract Res Clin Endocrinol Metab 22 5 (2008) 671-685
7. Chevalley T., Guilley E., Herrmann F.R., Hoffmeyer P., Rapin C.H., and Rizzoli R. Incidence of hip fracture over a 10-year period (1991-2000): reversal of a secular trend. Bone 40 5 (2007) 1284-1289
8. Kanis J.A., Johnell O., De Laet C., Johansson H., Oden A., Delmas P., et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone 35 2 (2004) 375-382
9. Klotzbuecher C.M., Ross P.D., Landsman P.B., Abbott T.A., and Berger M. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15 4 (2000) 721-739
10. Berry S.D., Samelson E.J., Hannan M.T., McLean R.R., Lu M., Cupples L.A., et al. Second hip fracture in older men and women: the Framingham Study. Arch Intern Med 167 18 (2007) 1971-1976
11. Ryg J., Rejnmark L., Overgaard S., Brixen K., and Vestergaard P. Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169,145 cases during 1977-2001. J Bone Miner Res 24 7 (2009) 1299-1307
12. Schuit S.C., van der Klift M., Weel A.E., de Laet C.E., Burger H., Seeman E., et al. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone 34 1 (2004) 195-202
13. Wainwright S.A., Marshall L.M., Ensrud K.E., Cauley J.A., Black D.M., Hillier T.A., et al. Hip fracture in women without osteoporosis. J Clin Endocrinol Metab 90 5 (2005) 2787-2793
14. Parkkari J., Kannus P., Palvanen M., Natri A., Vainio J., Aho H., et al. Majority of hip fractures occur as a result of a fall and impact on the greater trochanter of the femur: a prospective controlled hip fracture study with 206 consecutive patients. Calcif Tissue Int 65 3 (1999) 183-187
15. Kannus P., Sievanen H., Palvanen M., Jarvinen T., and Parkkari J. Prevention of falls and consequent injuries in elderly people. Lancet 366 9500 (2005) 1885-1893
16. Guideline for the prevention of falls in older persons. American Geriatrics Society, British Geriatrics Society, and American Academy of Orthopaedic Surgeons Panel on Falls Prevention. J Am Geriatr Soc 2001:49(5):664-72.
17. Leipzig R.M., Cumming R.G., and Tinetti M.E. Drugs and falls in older people: a systematic review and meta-analysis: II Cardiac and analgesic drugs. J Am Geriatr Soc 47 1 (1999) 40-50
18. Leipzig R.M., Cumming R.G., and Tinetti M.E. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 47 1 (1999) 30-39
19. Gillespie L.D., Robertson M.C., Gillespie W.J., Lamb S.E., Gates S., Cumming R.G., et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 2 (2009) CD007146
20. Close J., Ellis M., Hooper R., Glucksman E., Jackson S., and Swift C. Prevention of falls in the elderly trial (PROFET): a randomised controlled trial. Lancet 353 9147 (1999) 93-97
21. Hendriks M.R., Bleijlevens M.H., van Haastregt J.C., Crebolder H.F., Diederiks J.P., Evers S.M., et al. Lack of effectiveness of a multidisciplinary fall-prevention program in elderly people at risk: a randomized, controlled trial. J Am Geriatr Soc 56 8 (2008) 1390-1397
22. Lin M.R., Wolf S.L., Hwang H.F., Gong S.Y., and Chen C.Y. A randomized, controlled trial of fall prevention programs and quality of life in older fallers. J Am Geriatr Soc 55 4 (2007) 499-506
23. Berard A., Bravo G., and Gauthier P. Meta-analysis of the effectiveness of physical activity for the prevention of bone loss in postmenopausal women. Osteoporos Int 7 4 (1997) 331-337
24. Robertson M.C., Campbell A.J., Gardner M.M., and Devlin N. Preventing injuries in older people by preventing falls: a meta-analysis of individual-level data. J Am Geriatr Soc 50 5 (2002) 905-911
25. Kiel D.P., Magaziner J., Zimmerman S., Ball L., Barton B.A., Brown K.M., et al. Efficacy of a hip protector to prevent hip fracture in nursing home residents: the HIP PRO randomized controlled trial. JAMA 298 4 (2007) 413-422
26. Parker M.J., Gillespie W.J., and Gillespie L.D. Hip protectors for preventing hip fractures in older people. Cochrane Database Syst Rev 3 (2005) CD001255
27. Rizzoli R. Nutrition: its role in bone health. Best Pract Res Clin Endocrinol Metab 22 5 (2008) 813-829
28. Rizzoli R., Ammann P., Chevalley T., and Bonjour J.P. Protein intake and bone disorders in the elderly. Joint Bone Spine 68 5 (2001) 383-392
29. Rizzoli R., and Bonjour J.P. Dietary protein and bone health. J Bone Miner Res 19 4 (2004) 527-531
30. Munger R.G., Cerhan J.R., and Chiu B.C. Prospective study of dietary protein intake and risk of hip fracture in postmenopausal women. Am J Clin Nutr 69 1 (1999) 147-152
31. Darling AL, Millward DJ, Torgerson DJ, Hewitt CE, Lanham-New SA. Dietary protein and bone health: a systematic review and meta-analysis. Am J Clin Nutr 2009:90(6):1674-92.
32. Hannan M.T., Felson D.T., Dawson-Hughes B., Tucker K.L., Cupples L.A., Wilson P.W., et al. Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res 15 4 (2000) 710-720
33. Dawson-Hughes B., and Harris S.S. Calcium intake influences the association of protein intake with rates of bone loss in elderly men and women. Am J Clin Nutr 75 4 (2002) 773-779
34. Bergman H., Ferrucci L., Guralnik J., Hogan D.B., Hummel S., Karunananthan S., et al. Frailty: an emerging research and clinical paradigm--issues and controversies. J Gerontol A Biol Sci Med Sci 62 7 (2007) 731-737
35. Fried L.P., Ferrucci L., Darer J., Williamson J.D., and Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 59 3 (2004) 255-263
36. Salminen H., Saaf M., Johansson S.E., Ringertz H., and Strender L.E. Nutritional status, as determined by the Mini-Nutritional Assessment, and osteoporosis: a cross-sectional study of an elderly female population. Eur J Clin Nutr 60 4 (2006) 486-493
37. Fried L.P., Tangen C.M., Walston J., Newman A.B., Hirsch C., Gottdiener J., et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56 3 (2001) M146-M156
38. Ensrud K.E., Ewing S.K., Taylor B.C., Fink H.A., Stone K.L., Cauley J.A., et al. Frailty and risk of falls, fracture, and mortality in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci 62 7 (2007) 744-751
39. Ensrud KE, Ewing SK, Taylor BC, Fink HA, Cawthon PM, Stone KL, et al. Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. Arch Intern Med 2008:168(4):382-9.
40. Wagner H., Melhus H., Gedeborg R., Pedersen N.L., and Michaelsson K. Simply ask them about their balance--future fracture risk in a nationwide cohort study of twins. Am J Epidemiol 169 2 (2009) 143-149
41. Delmi M., Rapin C.H., Bengoa J.M., Delmas P.D., Vasey H., and Bonjour J.P. Dietary supplementation in elderly patients with fractured neck of the femur. Lancet 335 8696 (1990) 1013-1016
42. Tkatch L., Rapin C.H., Rizzoli R., Slosman D., Nydegger V., Vasey H., et al. Benefits of oral protein supplementation in elderly patients with fracture of the proximal femur. J Am Coll Nutr 11 5 (1992) 519-525
43. Schurch M.A., Rizzoli R., Slosman D., Vadas L., Vergnaud P., and Bonjour J.P. Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 128 10 (1998) 801-809
44. Auernhammer C.J., and Strasburger C.J. Effects of growth hormone and insulin-like growth factor I on the immune system. Eur J Endocrinol 133 6 (1995) 635-645
45. Rizzoli R, Bonjour JP. Physiology of calcium and phosphate homeostases. In: Seibel MJ, Robins SP, Bilezikian JP (eds.) Dynamics of Bone and Cartilage Metabolism, 2nd ed. Academic Press, San Diego; 2006, pp. 345-60.
46. Bischoff-Ferrari H.A., Dawson-Hughes B., Willett W.C., Staehelin H.B., Bazemore M.G., Zee R.Y., et al. Effect of Vitamin D on falls: a meta-analysis. JAMA 291 16 (2004) 1999-2006
47. Bischoff-Ferrari H.A., Dietrich T., Orav E.J., Hu F.B., Zhang Y., Karlson E.W., et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or = 60 y. Am J Clin Nutr 80 3 (2004) 752-758
48. Visser M., Deeg D.J., and Lips P. Longitudinal Aging Study Amsterdam Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 88 (2002) 5766-5772
49. Holick M.F. Vitamin D deficiency. N Engl J Med 357 3 (2007) 266-281
50. MacLaughlin J., and Holick M.F. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 76 4 (1985) 1536-1538
51. Cauley J.A., Lacroix A.Z., Wu L., Horwitz M., Danielson M.E., Bauer D.C., et al. Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med 149 4 (2008) 242-250
52. Lips P., Duong T., Oleksik A., Black D., Cummings S., Cox D., et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 86 3 (2001) 1212-1221
53. Neuprez A., Bruyere O., Collette J., and Reginster J.Y. Vitamin D inadequacy in Belgian postmenopausal osteoporotic women. BMC Public Health 7 (2007) 64
54. Bischoff-Ferrari H.A., Can U., Staehelin H.B., Platz A., Henschkowski J., Michel B.A., et al. Severe vitamin D deficiency in Swiss hip fracture patients. Bone 42 3 (2008) 597-602
55. Boonen S., Lips P., Bouillon R., Bischoff-Ferrari H.A., Vanderschueren D., and Haentjens P. Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab 92 4 (2007) 1415-1423
56. Bischoff-Ferrari H.A., Dawson-Hughes B., Staehelin H.B., Orav J.E., Stuck A.E., Theiler R., et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 339 (2009) b3692
57. Tang B.M., Eslick G.D., Nowson C., Smith C., and Bensoussan A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 370 9588 (2007) 657-666
58. Avenell A, Gillespie WJ, Gillespie LD, O'Connell D. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and postmenopausal osteoporosis. Cochrane Database Syst Rev 2009:(2);CD000227.
59. Grant A.M., Avenell A., Campbell M.K., McDonald A.M., MacLennan G.S., McPherson G.C., et al. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised evaluation of calcium or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 365 9471 (2005) 1621-1628
60. Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster JY, Borgstrom F, et al. 2008 European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 19(4):399-428. Erratum in: Osteoporos Int 2008:19:1103-4.
61. Boonen S., Laan R.F., Barton I.P., and Watts N.B. Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies. Osteoporos Int 16 10 (2005) 1291-1298
62. Rabenda V., Mertens R., Fabri V., Vanoverloop J., Sumkay F., Vannecke C., et al. Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women. Osteoporos Int 19 6 (2008) 811-818
63. Rabenda V., Vanoverloop J., Fabri V., Mertens R., Sumkay F., Vannecke C., et al. Low incidence of anti-osteoporosis treatment after hip fracture. J Bone Joint Surg Am 90 10 (2008) 2142-2148
64. Gehlbach S.H., Avrunin J.S., Puleo E., and Spaeth R. Fracture risk and antiresorptive medication use in older women in the USA. Osteoporos Int 18 6 (2007) 805-810
65. Andrade S.E., Majumdar S.R., Chan K.A., Buist D.S., Go A.S., Goodman M., et al. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med 163 17 (2003) 2052-2057
66. Chevalley T., Hoffmeyer P., Bonjour J.P., and Rizzoli R. An osteoporosis clinical pathway for the medical management of patients with low-trauma fracture. Osteoporos Int 13 6 (2002) 450-455
67. Rizzoli R., Bruyere O., Cannata-Andia J.B., Devogelaer J.P., Lyritis G., Ringe J.D., et al. Management of osteoporosis in the elderly. Curr Med Res Opin 25 10 (2009) 2373-2387
68. Inderjeeth C.A., Foo A.C., Lai M.M., and Glendenning P. Efficacy and safety of pharmacological agents in managing osteoporosis in the old: review of the evidence. Bone 44 5 (2009) 744-751
69. Boonen S., Dejaeger E., Vanderschueren D., Venken K., Bogaerts A., Verschueren S., et al. Osteoporosis and osteoporotic fracture occurrence and prevention in the elderly: a geriatric perspective. Best Pract Res Clin Endocrinol Metab 22 5 (2008) 765-785
70. Ensrud K.E., Black D.M., Palermo L., Bauer D.C., Barrett-Connor E., Quandt S.A., et al. Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial. Arch Intern Med 157 22 (1997) 2617-2624
71. Hochberg M.C., Thompson D.E., Black D.M., Quandt S.A., Cauley J., Geusens P., et al. Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures. J Bone Miner Res 20 6 (2005) 971-976
72. McClung M.R., Geusens P., Miller P.D., Zippel H., Bensen W.G., Roux C., et al. Effect of risedronate on the risk of hip fracture in elderly women Hip Intervention Program Study Group. N Engl J Med 344 5 (2001) 333-340
73. Boonen S., Marin F., Mellstrom D., Xie L., Desaiah D., Krege J.H., et al. Safety and efficacy of teriparatide in elderly women with established osteoporosis: bone anabolic therapy from a geriatric perspective. J Am Geriatr Soc 54 5 (2006) 782-789
74. McCloskey E.V., Beneton M., Charlesworth D., Kayan K., deTakats D., Dey A., et al. Clodronate reduces the incidence of fractures in community-dwelling elderly women unselected for osteoporosis: results of a double-blind, placebo-controlled randomized study. J Bone Miner Res 22 1 (2007) 135-141
75. Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, et al., HORIZON Pivotal Fracture Trial. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 2007:356(18):1809-22.
76. Rizzoli R. Zoledronic acid for the treatment and prevention of primary and secondary osteoporosis. Ther Adv Musculoskel Dis (in press).
77. Lyles K.W., Colon-Emeric C.S., Magaziner J.S., Adachi J.D., Pieper C.F., Mautalen C., et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357 18 (2007) 1799-1809
78. Cummings S.R., San Martin J., McClung M.R., Siris E.S., Eastell R., Reid I.R., et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361 8 (2009) 756-765
79. Boonen S., McClung M.R., Minisola S., Lippuner K., Torring O., Rizzoli R., et al. Effects of denosumab on the incidence of hip, new vertebral, and nonvertebral fractures over 3 years among postmenopausal women with higher fracture risk: a subgroup analysis from the FREEDOM study. Am Soc Bone Miner Res (2009)
80. Seeman E., Vellas B., Benhamou C., Aquino J.P., Semler J., Kaufman J.M., et al. Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older. J Bone Miner Res 21 7 (2006) 1113-1120
81. Seeman E., Boonen S., Borgstrom F., Vellas B., Aquino J.P., Semler J., et al. Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age. Bone (2009) [Epub ahead of print]
82. Jones T.J., Petrella R.J., and Crilly R. Determinants of persistence with weekly bisphosphonates in patients with osteoporosis. J Rheumatol 35 9 (2008) 1865-1873
83. Solomon D.H., Avorn J., Katz J.N., Finkelstein J.S., Arnold M., Polinski J.M., et al. Compliance with osteoporosis medications. Arch Intern Med 165 20 (2005) 2414-2419
84. Brankin E., Walker M., Lynch N., Aspray T., Lis Y., and Cowell W. The impact of dosing frequency on compliance and persistence with bisphosphonates among postmenopausal women in the UK: evidence from three databases. Curr Med Res Opin 22 7 (2006) 1249-1256
85. Cramer J.A., Amonkar M.M., Hebborn A., and Altman R. Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis. Curr Med Res Opin 21 9 (2005) 1453-1460
86. Rizzoli R, Greenspan SL, Bone G, IIIrd, Schnitzer TJ, Watts NB, Adami S, et al. Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis. J Bone Miner Res 2002:17(11):1988-96.
87. Boonen S., Vanderschueren D., Venken K., Milisen K., Delforge M., and Haentjens P. Recent developments in the management of postmenopausal osteoporosis with bisphosphonates: enhanced efficacy by enhanced compliance. J Intern Med 264 4 (2008) 315-332
88. Reginster J.Y., Malaise O., Neuprez A., Jouret V.E., and Close P. Intermittent bisphosphonate therapy in postmenopausal osteoporosis: progress to date. Drugs Aging 24 5 (2007) 351-359
89. Boonen S., McClung M.R., Eastell R., El-Hajj Fuleihan G., Barton I.P., and Delmas P. Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old. J Am Geriatr Soc 52 11 (2004) 1832-1839